Almaden Minerals Ltd. (USA)  

(Public, NYSEMKT:AAU)   Watch this stock  
Find more results for NYSEAMEX:AAU
+0.002 (0.26%)
Feb 5 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.62 - 0.65
52 week 0.48 - 1.15
Open 0.65
Vol / Avg. 53,223.00/99,584.00
Mkt cap 50.63M
P/E     -
Div/yield     -
EPS -0.15
Shares 78.06M
Beta 0.86
Inst. own 4%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 2136.50% -5898.92%
Operating margin 2103.06% -5099.32%
EBITD margin - -1217.48%
Return on average assets 17.72% -32.93%
Return on average equity 18.88% -34.24%
Employees 8 -
CDP Score - -


310-1385 8th Ave W
+1-604-6897644 (Phone)
+1-604-6897645 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Almaden Minerals Ltd. (Almaden) is an exploration-stage company that is engaged directly in the exploration and development of exploration and evaluation properties in Canada, United States and Mexico. The Company is engaged in the business of the acquisition, exploration and when warranted, development of mineral properties. As of December 31, 2014, none of the Company's property interests were beyond exploration stage. The Company has not generated any revenues from operations. The Company has two primary property interests, both in Mexico: the Tuligtic prospect, which includes the Ixtaca zone and the El Cobre copper-gold prospect. The Company owns a 100% interest in the El Cobre project. The El Cobre project is located adjoining the Caballo Blanco project in Veracruz State, Mexico. The Company's Ixtaca deposit, the epithermal gold-silver target within the Tuligtic Property, is located approximately eight kilometers northwest of the town of San Francisco Ixtacamaxtitlan.

Officers and directors

James Duane Poliquin Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Morgan J. Poliquin Ph.D. President, Chief Executive Officer, Director
Age: 41
Bio & Compensation  - Reuters
Korm Trieu Chief Financial Officer
Age: 48
Bio & Compensation  - Reuters
Douglas John McDonald Vice President - Corporate Development
Bio & Compensation  - Reuters
William J. Worrall Director
Bio & Compensation  - Reuters
Mark Thomas Brown Independent Director
Age: 45
Bio & Compensation  - Reuters
Gerald G. Carlson Ph.D. Independent Director
Age: 68
Bio & Compensation  - Reuters
John Daniel McCleary Independent Director
Age: 73
Bio & Compensation  - Reuters
Joseph H. Montgomery Ph.D. Independent Director
Age: 87
Bio & Compensation  - Reuters